CSIR-Central Drug Research Institute s osteoporosis drug will be the first drug of the institute to be used by patients in the United States.CDRI has given the license of its patented drug Caviunin Scaffold to Aveta Biomics which is a leader in .
The CSIR-Central Drug Research Institute (CDRI) has developed an indigenous RT-PCR diagnostic kit, called Om , for testing the new Omicron variant of Covid-19.It is the first kit made by any government institution, and the third to be made .
Om , an indigenous RT-PCR diagnostic kit, is likely to be launched in the second week of February, after it receives a nod from the Indian Council of Medical Research (ICMR). The kit will cost around Rs 150 and give the test result in around two hours.